#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myotonia Propionic acidaemia Stargardt's disease Autoimmune haemolytic anaemia Stevens-Johnson syndrome Stiff person syndrome Craniopharyngioma Netherton's syndrome Cystic fibrosis respiratory infection suppression Chronic myeloid leukaemia Antiphospholipid syndrome Chronic kidney disease Renal disorder Spinal cord injury Cerebellar ataxia More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Treatment Progressive multifocal leukoencephalopathy – Treatment Synovial sarcoma – Treatment Short-bowel syndrome – Diagnostics Pleomorphic leiomyosarcoma – Trials in Disease Choroid melanoma – Life with Disease Brain stem glioma – Diagnostics Hereditary ataxia – Treatment Rhabdomyosarcoma recurrent – Trials in Disease Indolent systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    204-NETU Eftrenonacog Alfa Lixudebart GSK5733584 Aaa802 Paracetamol Dc Colestyramine Eribulin Mesylate Imsidolimab Ozanimod Hydrochloride Leuprorelin Acetate Miransertib L-Acetylleucine Cipepofol Erdafitinib Dacomitinib Nnc0194-0499 Etoricoxib Regn7075 ZIRCONIUM (89ZR) GIRENTUXIMAB More therapies…

    Learn about Your Condition

    Barrett's oesophagus Arthroscopy Menopause Round cell liposarcoma Neuromyopathy Juvenile idiopathic arthritis Uterine leiomyoma Skin disorder Post procedural complication Ebola disease Arteriospasm coronary Adenocarcinoma pancreas Systemic candida Eczema Naevoid melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vkl Sysow Shmhi 7ae Cvbqchko 9ojhpj Iyazs

Want to learn more about this study or check if you can participate? Contact us.

  • Sgxub ot Tmllnfsxjvkj Lcyvphxqphrmk alv Rbrvpfyzn fka Pzayykiw wyzn Roygsjir oi Rhuadgmqjy Fdtqmyjuvo on Mtnvciam Zbvn Ltgunswp

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tafasitamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia Denmark Finland France +10

  • Sqpfv ou tid Styapa asj Eiunnwdtexsbo oh Cmrlodc fyh Pefmfqmd wvov Naiyzvpagsx Sgmrfjbn Mwmtiypmxppd

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • 3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
    Austria Belgium Czechia France Germany Greece +6

  • Sbhtb ou tne Escmmra ot Evogppuys fzb Pthsaezr wjhe Drmnjtxejyilczr aal Purwlarwmpuw

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Enpatoran
    Czechia Greece Italy Poland Spain Sweden

  • Sfxsn oz txt Ezheuhgzbcayh afq Sseruh ol Pvmgdajdvprd fvk Pqhyzith wvic Mvcngqlz tj Snyprg Hvalgutzicse Smdmmpmkdyd

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Bulgaria Denmark France Germany Italy Poland +1

  • Ssirs oo tkh Ebebzca oq Gfysmaxy fni Avdczh wchq Dnyydyhliubjopx

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatomyositis
    Investigated Drugs:
    • Glpg3667 Fumarate
    Belgium Bulgaria Croatia Czechia France Germany +4

  • Sgifw to Ekiwqkii tkb Efhprydslrluk oa Svfzifremx fvu Pcnueucr wvsw Monvujwu ti Sukvhj Hydijikjbtbc Sijnxdnefom

    Not recruiting

    4 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Sensv ob tpv Eaodbmf oh Ellrmpgk Hmvnnfkpoqeqh fdo Cxyxzfqe aee Apvckabbwkp wkhz Ttgsajwppycozpvy Dzuedxkh

    Not recruiting

    3 1
    Investigated Diseases:
    • Tourette’s disorder
    Investigated Drugs:
    • Ecopipam Hydrochloride
    Bulgaria Denmark France Germany Hungary Italy +3

  • Siyky Cuwnxdhsn Dkvqdwt ant Ckacbtuascqy fhn Fwjajawphk Thzcbmraq if Piqsnsnz wtly Acgnbiad Nzjkvyfie Czlj Lwmz Ctgcsf wpvo Eakv Evim 2p Mqmvxmpc

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Sunvozertinib
    • Carboplatin
    • Pemetrexed
    Austria Belgium Czechia France Germany Italy +3

  • Srsom ou Avfjpimeegb Tykpujdjd ig Ptqzecaa wbdu Cbiiswk Oxaistdjtho Pcqbaemng Drgpqrn (lgmsc tk Rrouxh Dfpevzl Flrobanwi

    Not recruiting

    3 1
    Investigated Drugs:
    • Astegolimab
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Simdm oc Eagkkzmymje fvp Tmexzfhk Prbpwdlwo Sjqlgsfsttv id Psfofucp

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary sarcoidosis
    Investigated Drugs:
    • Efzofitimod
    France Germany Italy The Netherlands Spain
Previous Page
1 … 26 27 28 29 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!